Literature DB >> 11024107

Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts.

P P Sanna1, D R Burton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11024107      PMCID： PMC102017          DOI： 10.1128/jvi.74.21.9813-9817.2000

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  86 in total

1.  Monoclonal antibodies suppress replication of herpes simplex virus type 1 in trigeminal ganglia.

Authors:  J E Oakes; R N Lausch
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

Review 2.  Diagnosis criteria and classification of human primary defects of humoral immunity.

Authors:  M Seligmann; J J Ballet
Journal:  Birth Defects Orig Artic Ser       Date:  1983

3.  Worldwide epidemiology of human adenovirus infections.

Authors:  H Schmitz; R Wigand; W Heinrich
Journal:  Am J Epidemiol       Date:  1983-04       Impact factor: 4.897

4.  Immunodeficiency measles encephalitis.

Authors:  D G Graham; A Gordon; B Ashworth; P L Yap
Journal:  J Clin Lab Immunol       Date:  1983-02

Review 5.  X-linked agammaglobulinemia: an analysis of 96 patients.

Authors:  H M Lederman; J A Winkelstein
Journal:  Medicine (Baltimore)       Date:  1985-05       Impact factor: 1.889

6.  Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases.

Authors:  H D Ochs; S H Fischer; R J Wedgwood; D W Wara; M J Cowan; A J Ammann; A Saxon; M D Budinger; R U Allred; R H Rousell
Journal:  Am J Med       Date:  1984-03-30       Impact factor: 4.965

7.  Pathogenesis of herpes simplex virus in B cell-suppressed mice: the relative roles of cell-mediated and humoral immunity.

Authors:  A K Kapoor; A A Nash; P Wildy
Journal:  J Gen Virol       Date:  1982-07       Impact factor: 3.891

8.  In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of Friend leukemia virus.

Authors:  E V Genovesi; J J Collins
Journal:  J Cell Physiol       Date:  1983-11       Impact factor: 6.384

9.  Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody.

Authors:  M J Buchmeier; H A Lewicki; P J Talbot; R L Knobler
Journal:  Virology       Date:  1984-01-30       Impact factor: 3.616

10.  Antibody-induced modulation of proteins in vesicular stomatitis virus-infected fibroblasts.

Authors:  E J O'Rourke; W H Guo; A S Huang
Journal:  Mol Cell Biol       Date:  1983-09       Impact factor: 4.272
View more
  15 in total

1.  Regulation of virus neutralization and the persistent fraction by TRIM21.

Authors:  W A McEwan; F Hauler; C R Williams; S R Bidgood; D L Mallery; R A Crowther; L C James
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

2.  Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics.

Authors:  Wen-Hsuan W Lin; Roger D Kouyos; Robert J Adams; Bryan T Grenfell; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-07       Impact factor: 11.205

3.  beta2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis.

Authors:  Karin Klingel; Jens-Jörg Schnorr; Martina Sauter; Gudrun Szalay; Reinhard Kandolf
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

4.  Targeting Insulin Receptor in Breast Cancer Using Small Engineered Protein Scaffolds.

Authors:  Jie Ying Chan; Benjamin J Hackel; Douglas Yee
Journal:  Mol Cancer Ther       Date:  2017-05-03       Impact factor: 6.261

Review 5.  Wanted, dead or alive: new viral vaccines.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Antiviral Res       Date:  2009-09-04       Impact factor: 5.970

6.  Associations of Viral Seroreactivity with AIDS-Related Non-Hodgkin Lymphoma.

Authors:  Minkyo Song; Bryan A Bassig; Noemi Bender; James J Goedert; Cheryl A Winkler; Nicole Brenner; Tim Waterboer; Charles S Rabkin
Journal:  AIDS Res Hum Retroviruses       Date:  2020-03-02       Impact factor: 2.205

7.  The role of neutralizing antibodies for mouse mammary tumor virus transmission and mammary cancer development.

Authors:  Daniela Finke; Sanjiv A Luther; Hans Acha-Orbea
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-26       Impact factor: 11.205

8.  Intracellular antibody receptor TRIM21 prevents fatal viral infection.

Authors:  Marina Vaysburd; Ruth E Watkinson; Helen Cooper; Martin Reed; Kevin O'Connell; Jackie Smith; James Cruickshanks; Leo C James
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-09       Impact factor: 11.205

9.  Impaired antibody response causes persistence of prototypic T cell-contained virus.

Authors:  Andreas Bergthaler; Lukas Flatz; Admar Verschoor; Ahmed N Hegazy; Martin Holdener; Katja Fink; Bruno Eschli; Doron Merkler; Rami Sommerstein; Edit Horvath; Marylise Fernandez; André Fitsche; Beatrice M Senn; J Sjef Verbeek; Bernhard Odermatt; Claire-Anne Siegrist; Daniel D Pinschewer
Journal:  PLoS Biol       Date:  2009-04-07       Impact factor: 8.029

10.  Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.

Authors:  Rami Sommerstein; Lukas Flatz; Melissa M Remy; Pauline Malinge; Giovanni Magistrelli; Nicolas Fischer; Mehmet Sahin; Andreas Bergthaler; Sebastien Igonet; Jan Ter Meulen; Dorothée Rigo; Paolo Meda; Nadia Rabah; Bruno Coutard; Thomas A Bowden; Paul-Henri Lambert; Claire-Anne Siegrist; Daniel D Pinschewer
Journal:  PLoS Pathog       Date:  2015-11-20       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.